news DelMar presents positive preclinical data on VAL-083 for treatment of non-small cell lung cancer 20 April 2015 | By Victoria White DelMar Pharmaceuticals presented positive preclinical data on its lead product candidate VAL-083 for treatment of platinum drug-resistant NSCLC at AACR2015...
news Blueprint Medicines presents preclinical data demonstrating significant anti-tumour activity of BLU-285 in treatment-resistant GIST 20 April 2015 | By Victoria White New preclinical data demonstrates that BLU-285 has significant anti-tumour activity in treatment-resistant models of gastrointestinal stromal tumours (GIST)...
news Oxford Global’s interview with Araz Raoof of Janssen Pharmaceuticals and Juan-Miguel Jimenez of Vertex Pharmaceuticals in the lead up to the 16th Annual Drug Discovery Summit 20 April 2015 | By Oxford Global Oxford Global is proud to present its 16th Annual Drug Discovery Summit and the co-located 3rd Annual Discovery Chemistry & Drug Design Congress taking place in Berlin on the 8th and 9th of June 2015...
news Peloton Therapeutics presents promising data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma 20 April 2015 | By Victoria White Peloton presented promising preclinical data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma, at AACR 2015...
news Consortium awarded €8.4 million for development of thermo stable and cold-chain independent virosome-based vaccines 20 April 2015 | By Victoria White Mymetics is leading a consortium to development thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.
news Novogen and the Feinstein Institute collaborate to develop effective treatments for brain cancers 17 April 2015 | By Victoria White Novogen and the Feinstein Institute for Medical Research are to collaborate to develop effective treatments for brain cancers...
news CiRA and Takeda to collaborate on iPS Cell Research 17 April 2015 | By Victoria White Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...
news Ferring and the Institut Pasteur collaborate in novel IDB drug development project 16 April 2015 | By Victoria White Ferring and Institut Pasteur are collaborating aimed at identifying and developing bacteriophages to treat patients with inflammatory bowel disease (IDB)...
news Celprogen introduces novel pharmacological inhibitor CEP1430 for the treatment of pancreatic cancer 15 April 2015 | By Victoria White Celprogen have developed a novel pharmacological Inhibitor, CEP1430, that is capable of inhibiting the growth of the human pancreatic cancer tumour...
news New preclinical data on G1T28 to be presented at AACR Annual Meeting 15 April 2015 | By Victoria White New preclinical data on G1 Therapeutics' lead compound G1T28 will be presented in a minisymposium and a poster session at the AACR Annual Meeting...
news Lexicon and Bristol-Myers Squibb select development candidate for neuropathic pain 15 April 2015 | By Victoria White Lexicon and Bristol-Myers Squibb have selected a development candidate for neuropathic pain as part of their drug discovery and development alliance...
news Medivir and CRT collaborate to develop new class of cancer drugs 13 April 2015 | By Victoria White Medivir and CRT have announced a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers...
news Broad Institute and Bayer HealthCare expand collaboration to help create new cardiovascular therapies 13 April 2015 | By Victoria White Bayer HealthCare has expanded its collaboration with the Broad Institute to include cardiovascular genomics and drug discovery...
news Genomics plc and Eisai to collaborate in analyses of large-scale genotype / phenotype data to inform drug discovery 13 April 2015 | By Victoria White Eisai and Genomics are to collaborate to use Genomics' statistical analyses of large-scale multi-phenotype data to inform Eisai's drug discovery process...
news New study reveals Anisina kills melanoma cells regardless of their mutation status 9 April 2015 | By Victoria White Novogen has announced that studies conducted at UQDI revealed that experimental drug Anisina killed melanoma cells irrespective of their mutational status...
